Clinical Research & Patient Care Core (CRPCC)
Clinical Research & Patient Care Core (CRPCC)
批准号:
10431471
负责人:
Larry S. Schlesinger
金额:
$19.99万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-10 至 2027-02-28
关键词:
AddressAmbulatory Care FacilitiesBiomedical ResearchCaringCause of DeathChestCitiesClinicClinicalClinical ManagementClinical ResearchClinical ServicesCollectionCommunicable DiseasesCommunicationCommunitiesComplexConsultationsCountryCustomDataData AnalysesDevelopmentDiabetes MellitusDisciplineEducationEducational CurriculumEnrollmentEpidemiologyEthicsEvaluationExtreme drug resistant tuberculosisField WorkersFoundationsFundingFunding AgencyFutureHealthHealth ProfessionalHomelessnessHospitalsHuman Subject ResearchHybridsIncidenceInfrastructureInpatientsInstitutesInstitutionKnowledgeLaboratoriesLeadershipLearningLength of StayLogisticsMedicalMentorsMexicanMexicoMissionMultidrug-Resistant TuberculosisNon-Insulin-Dependent Diabetes MellitusOralOutpatientsParticipantPathogenesisPatient CarePatientsPersonsPhysiciansPilot ProjectsPopulationPrevention strategyQualitative EvaluationsQuantitative EvaluationsResearchResearch DesignResearch InstituteResearch PersonnelResearch TrainingResourcesRotationScienceSideSiteSocial ProblemsSouth TexasSpecimenSpecimen HandlingStructureTexasThoracic RadiographyTrainingTreatment outcomeTuberculosisUniversitiesVaccinesWorkbiocontainment facilityclinical careclinical centerclinical research sitecomorbiditycritical periodcurriculum enhancementdesigndiagnostic strategyexperiencefield studyhuman old age (65+)improvedinterdisciplinary approachinterdisciplinary curriculuminterestlaboratory experimentmembermetropolitanmultidisciplinarynext generationpeerpreventprogramsprospectiveresearch studyskillssocialsuccesstherapy adverse effecttooltransmission processtreatment strategytuberculosis diagnosticstuberculosis treatmentvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
IN-TRAC Clinical Research & Patient Care Core (CRPCC) ABSTRACT
Tuberculosis (TB) is a leading infectious disease cause of death worldwide. In the US, TB incidence rates are
historically low, but control remains challenging in certain populations, including the communities along the US
border with Mexico. Thus, there is an urgent need for the next generation of TB researchers to have an
understanding of the clinical and epidemiological aspects of TB research, as a foundation for their future
leadership in the development of improved TB diagnostics, surveillance, treatments and vaccines. The Clinical
Research & Patient Care Core (CRPCC) of the IN-TRAC will provide to New TB Investigators (NIs) and
investigators new to the TB field, the infrastructure, resources and training in TB clinical research, and education
on the challenges faced by clinicians in managing TB cases. Our training sites are strategically located in south
Texas, a state adjacent to Mexico, which is the number one country of origin for foreign-born TB cases in the
US. The TB clinical research site is led by Dr. Restrepo, an expert in TB field epidemiology and pathogenesis in
TB patients with diabetes comorbidity or old age. Her field site is unique within the US due to its access to TB
patients enrolled on the Mexican side of the Texas border. The TB patient care training will be in San Antonio,
led by Drs. Armitige and Seaworth, an exemplary team of physicians who are affiliated with the only free-standing
TB hospital in the US, the Texas Center for Infectious Diseases (TCID). In the same setting, there are also busy
outpatient clinics: The San Antonio Metropolitan Health Department Chest Clinic, and a TB regional training and
medical consultation Center of Excellence (The Heartland National TB Center; HNTBC). Our Aims are to: Aim
1. Execute a personalized training curriculum on TB clinical research studies. We have designed a hybrid
(hands-on and virtual) training curriculum for IN-TRAC participants on all aspects of Clinical TB Research,
including ethics, study design, field logistics, data and specimen management, specimen processing and data
analysis plans and communications. Aim 2. Execute a personalized training curriculum on TB patient care.
IN-TRAC participants will be educated on the complex set of decisions that physicians make, particularly during
the management of difficult TB cases (e.g. with DR-TB, or with social problems such as homelessness), and
who require specialized management and prolonged in-hospital stays.
The mentoring team will meet with each IN-TRAC participant prior to their rotation to discuss customization of
the core curriculum, including the development of a pilot project, depending on the IN-TRAC participant’s interest.
IN-TRAC participants will provide a written and oral evaluation of their training experience.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10431466
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
-
批准号:10588203
-
项目类别:
-
资助金额:$115.01万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Administrative Core
-
批准号:10588204
-
项目类别:
-
资助金额:$8.61万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
-
批准号:10431465
-
项目类别:
-
资助金额:$119.94万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Clinical Research & Patient Care Core (CRPCC)
-
批准号:10588232
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
-
批准号:10450960
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
-
批准号:10457308
-
项目类别:
-
资助金额:$70.68万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection- Diversity Supplement
-
批准号:10116937
-
项目类别:
-
资助金额:$3.46万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Expansion of Marmoset Breeding Facilities to Meet Increasing Research Demands
-
批准号:9933536
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
-
批准号:10215474
-
项目类别:
-
资助金额:$70.68万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:8448670
-
项目类别:
-
资助金额:$60.84万
-
财政年份:2013
-
负责人:Larry S. Schlesinger
-
依托单位:
TB and Innate Immune Regulation of Lung Macrophages
-
批准号:8499656
-
项目类别:
-
资助金额:$6.45万
-
财政年份:2012
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:8233341
-
项目类别:
-
资助金额:$60.46万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8501526
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8689090
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8078747
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8878287
-
项目类别:
-
资助金额:$19.55万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8278528
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Acquisition of a MALDI-TOF/TOF MS for Glycomic and Lipidomic Research
-
批准号:7794367
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2010
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:7672070
-
项目类别:
-
资助金额:$54.59万
-
财政年份:2009
-
负责人:Larry S. Schlesinger
-
依托单位: